Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Sets High Bar For Approval Of Merck’s COX-2 Arcoxia

Apr 11 2007

• By Andrew Kasper

Related Content

Arcoxia Advisory Committee Will Be Missing Key Participants From 2005 COX-2 Meeting

Apr 11 2007

Merck’s Vioxx Successor Arcoxia May Be Closer To Market

Aug 23 2006

Merck Seeks Narrowed Arcoxia Indication In Response To “Approvable” Letter

Nov 10 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window